Blog

Most physicians have no idea what the medication they prescribe will cost a patient (or a payer). We give our members that information, especially when and where it matters most.

Drug prices are in the news again, but the latest attempts to lower them don't look very promising. Meanwhile, our solution keeps delivering on its promises.

We don't know how many of our 7 million-plus members have been furloughed or have reduced incomes. All we know is our solution keeps working for them, and for their employers and health plans too.

Using our own solution helps us evaluate and evolve everything that goes into it. More than anything, we need it just as much as anyone else. We're all consumers looking for help.

The mental health medication landscape is unique, but our solution always finds the savings opportunities—including this massive one.

Whatever the next normal looks like, and whenever we get there, our goal is still the same: make the world a better place for our members and clients.

The rush to recommend an unproven drug for COVID-19 led to shortages or unnecessary expense for patients who actually benefit from it. Once again, our solution and support team stepped up.

We may be working from 150 different home offices right now, but a quick visit to six of them illustrates how all our teams come together to help members during this pandemic—and all the time.

We caught a big price hike for the active ingredient in hydroxycholorquine, hailed by some as an effective COVID-19 treatment. Whatever the outcome on tablet prices, our solution is already helping affected members.

In a time when consumers and companies are under great financial stress, here's an example of how we help our members and our clients save precious dollars. We're talking thousands every fill!

What can consumers and payers expect in 2020 when it comes to drug prices? Probably more of the same from the industry and Washington. Learn why our CEO is so optimistic that real change is already under way.